nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymorphone—Ileus paralytic—Vinblastine—germ cell cancer	0.0301	0.0351	CcSEcCtD
Oxymorphone—OPRM1—telencephalic ventricle—germ cell cancer	0.0217	0.152	CbGeAlD
Oxymorphone—OPRD1—ganglion—germ cell cancer	0.0198	0.139	CbGeAlD
Oxymorphone—Swelling face—Ifosfamide—germ cell cancer	0.0197	0.023	CcSEcCtD
Oxymorphone—Ileus—Vinblastine—germ cell cancer	0.0184	0.0214	CcSEcCtD
Oxymorphone—OPRM1—ganglion—germ cell cancer	0.0135	0.0948	CbGeAlD
Oxymorphone—Ileus—Ifosfamide—germ cell cancer	0.0133	0.0155	CcSEcCtD
Oxymorphone—Drug interaction—Ifosfamide—germ cell cancer	0.0101	0.0118	CcSEcCtD
Oxymorphone—Laryngospasm—Etoposide—germ cell cancer	0.00993	0.0116	CcSEcCtD
Oxymorphone—Depressed level of consciousness—Ifosfamide—germ cell cancer	0.00907	0.0106	CcSEcCtD
Oxymorphone—Disorientation—Bleomycin—germ cell cancer	0.00892	0.0104	CcSEcCtD
Oxymorphone—Apnoea—Etoposide—germ cell cancer	0.00875	0.0102	CcSEcCtD
Oxymorphone—CYP3A4—urine—germ cell cancer	0.00809	0.0567	CbGeAlD
Oxymorphone—CYP2D6—urine—germ cell cancer	0.00796	0.0558	CbGeAlD
Oxymorphone—OPRD1—telencephalon—germ cell cancer	0.00765	0.0536	CbGeAlD
Oxymorphone—Disorientation—Ifosfamide—germ cell cancer	0.00762	0.00889	CcSEcCtD
Oxymorphone—Lethargy—Dactinomycin—germ cell cancer	0.00759	0.00885	CcSEcCtD
Oxymorphone—Amnesia—Ifosfamide—germ cell cancer	0.00725	0.00846	CcSEcCtD
Oxymorphone—Bronchospasm—Bleomycin—germ cell cancer	0.00678	0.00791	CcSEcCtD
Oxymorphone—Urinary retention—Ifosfamide—germ cell cancer	0.00648	0.00756	CcSEcCtD
Oxymorphone—Lung disorder—Methotrexate—germ cell cancer	0.00628	0.00732	CcSEcCtD
Oxymorphone—Amnesia—Cisplatin—germ cell cancer	0.00625	0.0073	CcSEcCtD
Oxymorphone—Weight decreased—Bleomycin—germ cell cancer	0.00624	0.00727	CcSEcCtD
Oxymorphone—Pneumonia—Bleomycin—germ cell cancer	0.00618	0.00721	CcSEcCtD
Oxymorphone—OPRM1—brainstem—germ cell cancer	0.00588	0.0412	CbGeAlD
Oxymorphone—Bronchospasm—Ifosfamide—germ cell cancer	0.00579	0.00676	CcSEcCtD
Oxymorphone—Pneumonia—Dactinomycin—germ cell cancer	0.00577	0.00673	CcSEcCtD
Oxymorphone—Dehydration—Cisplatin—germ cell cancer	0.00546	0.00637	CcSEcCtD
Oxymorphone—Orthostatic hypotension—Cisplatin—germ cell cancer	0.00537	0.00626	CcSEcCtD
Oxymorphone—Pneumonia—Ifosfamide—germ cell cancer	0.00528	0.00616	CcSEcCtD
Oxymorphone—Apnoea—Methotrexate—germ cell cancer	0.00524	0.00611	CcSEcCtD
Oxymorphone—OPRM1—telencephalon—germ cell cancer	0.00522	0.0366	CbGeAlD
Oxymorphone—Flushing—Bleomycin—germ cell cancer	0.00512	0.00597	CcSEcCtD
Oxymorphone—Vertigo—Vinblastine—germ cell cancer	0.00511	0.00596	CcSEcCtD
Oxymorphone—Sweating increased—Cisplatin—germ cell cancer	0.00495	0.00577	CcSEcCtD
Oxymorphone—Convulsion—Vinblastine—germ cell cancer	0.00493	0.00575	CcSEcCtD
Oxymorphone—Hypertension—Vinblastine—germ cell cancer	0.00491	0.00573	CcSEcCtD
Oxymorphone—Oliguria—Methotrexate—germ cell cancer	0.00482	0.00562	CcSEcCtD
Oxymorphone—Bradycardia—Ifosfamide—germ cell cancer	0.0048	0.0056	CcSEcCtD
Oxymorphone—Flushing—Dactinomycin—germ cell cancer	0.00478	0.00557	CcSEcCtD
Oxymorphone—OPRD1—head—germ cell cancer	0.00476	0.0334	CbGeAlD
Oxymorphone—Hallucination—Ifosfamide—germ cell cancer	0.00469	0.00547	CcSEcCtD
Oxymorphone—Urinary tract disorder—Ifosfamide—germ cell cancer	0.00466	0.00543	CcSEcCtD
Oxymorphone—Urethral disorder—Ifosfamide—germ cell cancer	0.00462	0.00539	CcSEcCtD
Oxymorphone—Bronchospasm—Etoposide—germ cell cancer	0.00458	0.00534	CcSEcCtD
Oxymorphone—OPRK1—head—germ cell cancer	0.00457	0.032	CbGeAlD
Oxymorphone—Visual impairment—Ifosfamide—germ cell cancer	0.00454	0.0053	CcSEcCtD
Oxymorphone—Sweating increased—Etoposide—germ cell cancer	0.00453	0.00529	CcSEcCtD
Oxymorphone—Anorexia—Vinblastine—germ cell cancer	0.00442	0.00516	CcSEcCtD
Oxymorphone—Eye disorder—Ifosfamide—germ cell cancer	0.00441	0.00514	CcSEcCtD
Oxymorphone—Cardiac disorder—Ifosfamide—germ cell cancer	0.00438	0.0051	CcSEcCtD
Oxymorphone—Flushing—Ifosfamide—germ cell cancer	0.00438	0.0051	CcSEcCtD
Oxymorphone—Depressed level of consciousness—Methotrexate—germ cell cancer	0.00429	0.005	CcSEcCtD
Oxymorphone—Angiopathy—Ifosfamide—germ cell cancer	0.00428	0.00499	CcSEcCtD
Oxymorphone—Immune system disorder—Ifosfamide—germ cell cancer	0.00426	0.00497	CcSEcCtD
Oxymorphone—Mediastinal disorder—Ifosfamide—germ cell cancer	0.00425	0.00496	CcSEcCtD
Oxymorphone—Pneumonia—Etoposide—germ cell cancer	0.00417	0.00487	CcSEcCtD
Oxymorphone—Bradycardia—Cisplatin—germ cell cancer	0.00414	0.00483	CcSEcCtD
Oxymorphone—Mental disorder—Ifosfamide—germ cell cancer	0.00413	0.00482	CcSEcCtD
Oxymorphone—Malnutrition—Ifosfamide—germ cell cancer	0.0041	0.00479	CcSEcCtD
Oxymorphone—Chest pain—Bleomycin—germ cell cancer	0.00409	0.00477	CcSEcCtD
Oxymorphone—OPRK1—cerebellum—germ cell cancer	0.00408	0.0286	CbGeAlD
Oxymorphone—Decreased appetite—Vinblastine—germ cell cancer	0.00403	0.00471	CcSEcCtD
Oxymorphone—Urinary tract disorder—Cisplatin—germ cell cancer	0.00401	0.00468	CcSEcCtD
Oxymorphone—Urethral disorder—Cisplatin—germ cell cancer	0.00398	0.00465	CcSEcCtD
Oxymorphone—Pain—Vinblastine—germ cell cancer	0.00397	0.00463	CcSEcCtD
Oxymorphone—Constipation—Vinblastine—germ cell cancer	0.00397	0.00463	CcSEcCtD
Oxymorphone—Confusional state—Bleomycin—germ cell cancer	0.00395	0.00461	CcSEcCtD
Oxymorphone—Oedema—Bleomycin—germ cell cancer	0.00392	0.00457	CcSEcCtD
Oxymorphone—Visual impairment—Cisplatin—germ cell cancer	0.00392	0.00457	CcSEcCtD
Oxymorphone—Vision blurred—Ifosfamide—germ cell cancer	0.00387	0.00451	CcSEcCtD
Oxymorphone—Feeling abnormal—Vinblastine—germ cell cancer	0.00382	0.00446	CcSEcCtD
Oxymorphone—Eye disorder—Cisplatin—germ cell cancer	0.0038	0.00443	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Vinblastine—germ cell cancer	0.0038	0.00443	CcSEcCtD
Oxymorphone—Cardiac disorder—Cisplatin—germ cell cancer	0.00377	0.0044	CcSEcCtD
Oxymorphone—Flushing—Cisplatin—germ cell cancer	0.00377	0.0044	CcSEcCtD
Oxymorphone—Agitation—Ifosfamide—germ cell cancer	0.00377	0.0044	CcSEcCtD
Oxymorphone—OPRM1—midbrain—germ cell cancer	0.00375	0.0263	CbGeAlD
Oxymorphone—Anorexia—Bleomycin—germ cell cancer	0.00374	0.00436	CcSEcCtD
Oxymorphone—Vertigo—Ifosfamide—germ cell cancer	0.00369	0.0043	CcSEcCtD
Oxymorphone—Urinary tract disorder—Etoposide—germ cell cancer	0.00368	0.00429	CcSEcCtD
Oxymorphone—Immune system disorder—Cisplatin—germ cell cancer	0.00367	0.00428	CcSEcCtD
Oxymorphone—Abdominal pain—Vinblastine—germ cell cancer	0.00367	0.00428	CcSEcCtD
Oxymorphone—Mediastinal disorder—Cisplatin—germ cell cancer	0.00366	0.00427	CcSEcCtD
Oxymorphone—Hypotension—Bleomycin—germ cell cancer	0.00366	0.00427	CcSEcCtD
Oxymorphone—OPRM1—spinal cord—germ cell cancer	0.00366	0.0256	CbGeAlD
Oxymorphone—Oedema—Dactinomycin—germ cell cancer	0.00366	0.00426	CcSEcCtD
Oxymorphone—Urethral disorder—Etoposide—germ cell cancer	0.00365	0.00426	CcSEcCtD
Oxymorphone—Palpitations—Ifosfamide—germ cell cancer	0.00363	0.00423	CcSEcCtD
Oxymorphone—Convulsion—Ifosfamide—germ cell cancer	0.00356	0.00415	CcSEcCtD
Oxymorphone—Hypertension—Ifosfamide—germ cell cancer	0.00354	0.00413	CcSEcCtD
Oxymorphone—Malnutrition—Cisplatin—germ cell cancer	0.00354	0.00413	CcSEcCtD
Oxymorphone—Dyspnoea—Bleomycin—germ cell cancer	0.00349	0.00408	CcSEcCtD
Oxymorphone—Chest pain—Ifosfamide—germ cell cancer	0.00349	0.00408	CcSEcCtD
Oxymorphone—Flatulence—Cisplatin—germ cell cancer	0.00349	0.00407	CcSEcCtD
Oxymorphone—Anorexia—Dactinomycin—germ cell cancer	0.00348	0.00406	CcSEcCtD
Oxymorphone—Eye disorder—Etoposide—germ cell cancer	0.00348	0.00406	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00347	0.00405	CcSEcCtD
Oxymorphone—Flushing—Etoposide—germ cell cancer	0.00346	0.00403	CcSEcCtD
Oxymorphone—Cardiac disorder—Etoposide—germ cell cancer	0.00346	0.00403	CcSEcCtD
Oxymorphone—OPRD1—brain—germ cell cancer	0.00345	0.0242	CbGeAlD
Oxymorphone—Hypersensitivity—Vinblastine—germ cell cancer	0.00342	0.00399	CcSEcCtD
Oxymorphone—Decreased appetite—Bleomycin—germ cell cancer	0.00341	0.00397	CcSEcCtD
Oxymorphone—Visual disturbance—Methotrexate—germ cell cancer	0.0034	0.00397	CcSEcCtD
Oxymorphone—Angiopathy—Etoposide—germ cell cancer	0.00338	0.00394	CcSEcCtD
Oxymorphone—Confusional state—Ifosfamide—germ cell cancer	0.00338	0.00394	CcSEcCtD
Oxymorphone—Immune system disorder—Etoposide—germ cell cancer	0.00336	0.00392	CcSEcCtD
Oxymorphone—Mediastinal disorder—Etoposide—germ cell cancer	0.00336	0.00392	CcSEcCtD
Oxymorphone—Pain—Bleomycin—germ cell cancer	0.00335	0.00391	CcSEcCtD
Oxymorphone—Oedema—Ifosfamide—germ cell cancer	0.00335	0.00391	CcSEcCtD
Oxymorphone—Vision blurred—Cisplatin—germ cell cancer	0.00334	0.00389	CcSEcCtD
Oxymorphone—Asthenia—Vinblastine—germ cell cancer	0.00333	0.00388	CcSEcCtD
Oxymorphone—OPRK1—brain—germ cell cancer	0.00331	0.0232	CbGeAlD
Oxymorphone—OPRM1—endocrine gland—germ cell cancer	0.00329	0.0231	CbGeAlD
Oxymorphone—Lethargy—Methotrexate—germ cell cancer	0.00329	0.00384	CcSEcCtD
Oxymorphone—Nervous system disorder—Ifosfamide—germ cell cancer	0.00329	0.00383	CcSEcCtD
Oxymorphone—Skin disorder—Ifosfamide—germ cell cancer	0.00325	0.0038	CcSEcCtD
Oxymorphone—OPRM1—head—germ cell cancer	0.00325	0.0228	CbGeAlD
Oxymorphone—Hyperhidrosis—Ifosfamide—germ cell cancer	0.00324	0.00378	CcSEcCtD
Oxymorphone—Feeling abnormal—Bleomycin—germ cell cancer	0.00323	0.00377	CcSEcCtD
Oxymorphone—Anorexia—Ifosfamide—germ cell cancer	0.00319	0.00372	CcSEcCtD
Oxymorphone—Decreased appetite—Dactinomycin—germ cell cancer	0.00318	0.00371	CcSEcCtD
Oxymorphone—Diarrhoea—Vinblastine—germ cell cancer	0.00318	0.0037	CcSEcCtD
Oxymorphone—Fatigue—Dactinomycin—germ cell cancer	0.00315	0.00368	CcSEcCtD
Oxymorphone—OPRM1—testis—germ cell cancer	0.00314	0.022	CbGeAlD
Oxymorphone—Hypotension—Ifosfamide—germ cell cancer	0.00313	0.00365	CcSEcCtD
Oxymorphone—Pain—Dactinomycin—germ cell cancer	0.00313	0.00365	CcSEcCtD
Oxymorphone—Urticaria—Bleomycin—germ cell cancer	0.00311	0.00363	CcSEcCtD
Oxymorphone—Body temperature increased—Bleomycin—germ cell cancer	0.0031	0.00361	CcSEcCtD
Oxymorphone—Dizziness—Vinblastine—germ cell cancer	0.00307	0.00358	CcSEcCtD
Oxymorphone—Convulsion—Cisplatin—germ cell cancer	0.00307	0.00358	CcSEcCtD
Oxymorphone—Feeling abnormal—Dactinomycin—germ cell cancer	0.00301	0.00351	CcSEcCtD
Oxymorphone—Anxiety—Cisplatin—germ cell cancer	0.003	0.0035	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00299	0.00349	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00299	0.00349	CcSEcCtD
Oxymorphone—Dyspnoea—Ifosfamide—germ cell cancer	0.00299	0.00348	CcSEcCtD
Oxymorphone—Somnolence—Ifosfamide—germ cell cancer	0.00298	0.00347	CcSEcCtD
Oxymorphone—Vomiting—Vinblastine—germ cell cancer	0.00295	0.00344	CcSEcCtD
Oxymorphone—Vertigo—Etoposide—germ cell cancer	0.00291	0.0034	CcSEcCtD
Oxymorphone—Decreased appetite—Ifosfamide—germ cell cancer	0.00291	0.0034	CcSEcCtD
Oxymorphone—Headache—Vinblastine—germ cell cancer	0.00291	0.00339	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00289	0.00337	CcSEcCtD
Oxymorphone—Abdominal pain—Dactinomycin—germ cell cancer	0.00289	0.00337	CcSEcCtD
Oxymorphone—Body temperature increased—Dactinomycin—germ cell cancer	0.00289	0.00337	CcSEcCtD
Oxymorphone—Fatigue—Ifosfamide—germ cell cancer	0.00289	0.00337	CcSEcCtD
Oxymorphone—Oedema—Cisplatin—germ cell cancer	0.00289	0.00337	CcSEcCtD
Oxymorphone—Hypersensitivity—Bleomycin—germ cell cancer	0.00289	0.00337	CcSEcCtD
Oxymorphone—Constipation—Ifosfamide—germ cell cancer	0.00286	0.00334	CcSEcCtD
Oxymorphone—Pain—Ifosfamide—germ cell cancer	0.00286	0.00334	CcSEcCtD
Oxymorphone—Loss of consciousness—Etoposide—germ cell cancer	0.00285	0.00332	CcSEcCtD
Oxymorphone—Nervous system disorder—Cisplatin—germ cell cancer	0.00283	0.0033	CcSEcCtD
Oxymorphone—Tachycardia—Cisplatin—germ cell cancer	0.00282	0.00329	CcSEcCtD
Oxymorphone—Asthenia—Bleomycin—germ cell cancer	0.00281	0.00328	CcSEcCtD
Oxymorphone—Convulsion—Etoposide—germ cell cancer	0.00281	0.00328	CcSEcCtD
Oxymorphone—Skin disorder—Cisplatin—germ cell cancer	0.00281	0.00327	CcSEcCtD
Oxymorphone—Hypertension—Etoposide—germ cell cancer	0.0028	0.00327	CcSEcCtD
Oxymorphone—Hyperhidrosis—Cisplatin—germ cell cancer	0.00279	0.00326	CcSEcCtD
Oxymorphone—Pruritus—Bleomycin—germ cell cancer	0.00277	0.00324	CcSEcCtD
Oxymorphone—Feeling abnormal—Ifosfamide—germ cell cancer	0.00276	0.00322	CcSEcCtD
Oxymorphone—Chest pain—Etoposide—germ cell cancer	0.00276	0.00322	CcSEcCtD
Oxymorphone—Nausea—Vinblastine—germ cell cancer	0.00276	0.00322	CcSEcCtD
Oxymorphone—Anorexia—Cisplatin—germ cell cancer	0.00275	0.00321	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.00274	0.0032	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00274	0.0032	CcSEcCtD
Oxymorphone—Hypotension—Cisplatin—germ cell cancer	0.0027	0.00315	CcSEcCtD
Oxymorphone—Hypersensitivity—Dactinomycin—germ cell cancer	0.00269	0.00314	CcSEcCtD
Oxymorphone—Confusional state—Etoposide—germ cell cancer	0.00267	0.00311	CcSEcCtD
Oxymorphone—Urticaria—Ifosfamide—germ cell cancer	0.00266	0.0031	CcSEcCtD
Oxymorphone—Body temperature increased—Ifosfamide—germ cell cancer	0.00265	0.00309	CcSEcCtD
Oxymorphone—Abdominal pain—Ifosfamide—germ cell cancer	0.00265	0.00309	CcSEcCtD
Oxymorphone—Asthenia—Dactinomycin—germ cell cancer	0.00262	0.00306	CcSEcCtD
Oxymorphone—Tachycardia—Etoposide—germ cell cancer	0.00258	0.00301	CcSEcCtD
Oxymorphone—Dyspnoea—Cisplatin—germ cell cancer	0.00257	0.003	CcSEcCtD
Oxymorphone—Skin disorder—Etoposide—germ cell cancer	0.00257	0.003	CcSEcCtD
Oxymorphone—Hyperhidrosis—Etoposide—germ cell cancer	0.00256	0.00298	CcSEcCtD
Oxymorphone—Anorexia—Etoposide—germ cell cancer	0.00252	0.00294	CcSEcCtD
Oxymorphone—Decreased appetite—Cisplatin—germ cell cancer	0.00251	0.00293	CcSEcCtD
Oxymorphone—Diarrhoea—Dactinomycin—germ cell cancer	0.0025	0.00292	CcSEcCtD
Oxymorphone—Pneumonia—Methotrexate—germ cell cancer	0.0025	0.00292	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00249	0.00291	CcSEcCtD
Oxymorphone—Vomiting—Bleomycin—germ cell cancer	0.00249	0.00291	CcSEcCtD
Oxymorphone—Hypotension—Etoposide—germ cell cancer	0.00247	0.00288	CcSEcCtD
Oxymorphone—Pain—Cisplatin—germ cell cancer	0.00247	0.00288	CcSEcCtD
Oxymorphone—Dermatitis—Bleomycin—germ cell cancer	0.00247	0.00288	CcSEcCtD
Oxymorphone—Hypersensitivity—Ifosfamide—germ cell cancer	0.00247	0.00288	CcSEcCtD
Oxymorphone—Asthenia—Ifosfamide—germ cell cancer	0.0024	0.0028	CcSEcCtD
Oxymorphone—Feeling abnormal—Cisplatin—germ cell cancer	0.00238	0.00278	CcSEcCtD
Oxymorphone—Pruritus—Ifosfamide—germ cell cancer	0.00237	0.00276	CcSEcCtD
Oxymorphone—Dyspnoea—Etoposide—germ cell cancer	0.00236	0.00275	CcSEcCtD
Oxymorphone—CYP2D6—brainstem—germ cell cancer	0.00236	0.0165	CbGeAlD
Oxymorphone—OPRM1—brain—germ cell cancer	0.00235	0.0165	CbGeAlD
Oxymorphone—Somnolence—Etoposide—germ cell cancer	0.00235	0.00274	CcSEcCtD
Oxymorphone—Nausea—Bleomycin—germ cell cancer	0.00233	0.00272	CcSEcCtD
Oxymorphone—Vomiting—Dactinomycin—germ cell cancer	0.00232	0.00271	CcSEcCtD
Oxymorphone—Decreased appetite—Etoposide—germ cell cancer	0.0023	0.00268	CcSEcCtD
Oxymorphone—Diarrhoea—Ifosfamide—germ cell cancer	0.00229	0.00267	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00228	0.00266	CcSEcCtD
Oxymorphone—Body temperature increased—Cisplatin—germ cell cancer	0.00228	0.00266	CcSEcCtD
Oxymorphone—Fatigue—Etoposide—germ cell cancer	0.00228	0.00266	CcSEcCtD
Oxymorphone—Pain—Etoposide—germ cell cancer	0.00226	0.00264	CcSEcCtD
Oxymorphone—Constipation—Etoposide—germ cell cancer	0.00226	0.00264	CcSEcCtD
Oxymorphone—Dizziness—Ifosfamide—germ cell cancer	0.00222	0.00258	CcSEcCtD
Oxymorphone—Urinary tract disorder—Methotrexate—germ cell cancer	0.0022	0.00257	CcSEcCtD
Oxymorphone—Urethral disorder—Methotrexate—germ cell cancer	0.00219	0.00255	CcSEcCtD
Oxymorphone—Feeling abnormal—Etoposide—germ cell cancer	0.00218	0.00254	CcSEcCtD
Oxymorphone—Nausea—Dactinomycin—germ cell cancer	0.00217	0.00253	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Etoposide—germ cell cancer	0.00216	0.00252	CcSEcCtD
Oxymorphone—Visual impairment—Methotrexate—germ cell cancer	0.00215	0.00251	CcSEcCtD
Oxymorphone—Vomiting—Ifosfamide—germ cell cancer	0.00213	0.00248	CcSEcCtD
Oxymorphone—Hypersensitivity—Cisplatin—germ cell cancer	0.00213	0.00248	CcSEcCtD
Oxymorphone—Dermatitis—Ifosfamide—germ cell cancer	0.00211	0.00246	CcSEcCtD
Oxymorphone—Urticaria—Etoposide—germ cell cancer	0.0021	0.00245	CcSEcCtD
Oxymorphone—CYP2D6—telencephalon—germ cell cancer	0.00209	0.0147	CbGeAlD
Oxymorphone—Body temperature increased—Etoposide—germ cell cancer	0.00209	0.00244	CcSEcCtD
Oxymorphone—Abdominal pain—Etoposide—germ cell cancer	0.00209	0.00244	CcSEcCtD
Oxymorphone—Eye disorder—Methotrexate—germ cell cancer	0.00208	0.00243	CcSEcCtD
Oxymorphone—Asthenia—Cisplatin—germ cell cancer	0.00207	0.00242	CcSEcCtD
Oxymorphone—Cardiac disorder—Methotrexate—germ cell cancer	0.00207	0.00241	CcSEcCtD
Oxymorphone—Angiopathy—Methotrexate—germ cell cancer	0.00202	0.00236	CcSEcCtD
Oxymorphone—Immune system disorder—Methotrexate—germ cell cancer	0.00201	0.00235	CcSEcCtD
Oxymorphone—Mediastinal disorder—Methotrexate—germ cell cancer	0.00201	0.00235	CcSEcCtD
Oxymorphone—Nausea—Ifosfamide—germ cell cancer	0.00199	0.00232	CcSEcCtD
Oxymorphone—Diarrhoea—Cisplatin—germ cell cancer	0.00198	0.00231	CcSEcCtD
Oxymorphone—Mental disorder—Methotrexate—germ cell cancer	0.00195	0.00228	CcSEcCtD
Oxymorphone—Hypersensitivity—Etoposide—germ cell cancer	0.00195	0.00227	CcSEcCtD
Oxymorphone—Malnutrition—Methotrexate—germ cell cancer	0.00194	0.00227	CcSEcCtD
Oxymorphone—Asthenia—Etoposide—germ cell cancer	0.0019	0.00221	CcSEcCtD
Oxymorphone—Pruritus—Etoposide—germ cell cancer	0.00187	0.00218	CcSEcCtD
Oxymorphone—Vomiting—Cisplatin—germ cell cancer	0.00184	0.00214	CcSEcCtD
Oxymorphone—Vision blurred—Methotrexate—germ cell cancer	0.00183	0.00213	CcSEcCtD
Oxymorphone—Dermatitis—Cisplatin—germ cell cancer	0.00182	0.00212	CcSEcCtD
Oxymorphone—Diarrhoea—Etoposide—germ cell cancer	0.00181	0.00211	CcSEcCtD
Oxymorphone—Dizziness—Etoposide—germ cell cancer	0.00175	0.00204	CcSEcCtD
Oxymorphone—Vertigo—Methotrexate—germ cell cancer	0.00174	0.00204	CcSEcCtD
Oxymorphone—Nausea—Cisplatin—germ cell cancer	0.00172	0.002	CcSEcCtD
Oxymorphone—Convulsion—Methotrexate—germ cell cancer	0.00168	0.00196	CcSEcCtD
Oxymorphone—Vomiting—Etoposide—germ cell cancer	0.00168	0.00196	CcSEcCtD
Oxymorphone—Dermatitis—Etoposide—germ cell cancer	0.00167	0.00194	CcSEcCtD
Oxymorphone—Headache—Etoposide—germ cell cancer	0.00166	0.00193	CcSEcCtD
Oxymorphone—Chest pain—Methotrexate—germ cell cancer	0.00165	0.00193	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.00164	0.00192	CcSEcCtD
Oxymorphone—Confusional state—Methotrexate—germ cell cancer	0.0016	0.00186	CcSEcCtD
Oxymorphone—Nausea—Etoposide—germ cell cancer	0.00157	0.00183	CcSEcCtD
Oxymorphone—Nervous system disorder—Methotrexate—germ cell cancer	0.00155	0.00181	CcSEcCtD
Oxymorphone—Skin disorder—Methotrexate—germ cell cancer	0.00154	0.0018	CcSEcCtD
Oxymorphone—Hyperhidrosis—Methotrexate—germ cell cancer	0.00153	0.00179	CcSEcCtD
Oxymorphone—Anorexia—Methotrexate—germ cell cancer	0.00151	0.00176	CcSEcCtD
Oxymorphone—Hypotension—Methotrexate—germ cell cancer	0.00148	0.00173	CcSEcCtD
Oxymorphone—Insomnia—Methotrexate—germ cell cancer	0.00143	0.00167	CcSEcCtD
Oxymorphone—CYP2D6—female gonad—germ cell cancer	0.00142	0.00994	CbGeAlD
Oxymorphone—Dyspnoea—Methotrexate—germ cell cancer	0.00141	0.00165	CcSEcCtD
Oxymorphone—Somnolence—Methotrexate—germ cell cancer	0.00141	0.00164	CcSEcCtD
Oxymorphone—Dyspepsia—Methotrexate—germ cell cancer	0.0014	0.00163	CcSEcCtD
Oxymorphone—Decreased appetite—Methotrexate—germ cell cancer	0.00138	0.00161	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.00137	0.0016	CcSEcCtD
Oxymorphone—Fatigue—Methotrexate—germ cell cancer	0.00137	0.00159	CcSEcCtD
Oxymorphone—Pain—Methotrexate—germ cell cancer	0.00136	0.00158	CcSEcCtD
Oxymorphone—CYP3A4—endocrine gland—germ cell cancer	0.00134	0.0094	CbGeAlD
Oxymorphone—CYP2D6—endocrine gland—germ cell cancer	0.00132	0.00925	CbGeAlD
Oxymorphone—Feeling abnormal—Methotrexate—germ cell cancer	0.00131	0.00152	CcSEcCtD
Oxymorphone—CYP2D6—head—germ cell cancer	0.0013	0.00913	CbGeAlD
Oxymorphone—Gastrointestinal pain—Methotrexate—germ cell cancer	0.0013	0.00151	CcSEcCtD
Oxymorphone—Urticaria—Methotrexate—germ cell cancer	0.00126	0.00147	CcSEcCtD
Oxymorphone—CYP2D6—testis—germ cell cancer	0.00126	0.00882	CbGeAlD
Oxymorphone—Body temperature increased—Methotrexate—germ cell cancer	0.00125	0.00146	CcSEcCtD
Oxymorphone—Abdominal pain—Methotrexate—germ cell cancer	0.00125	0.00146	CcSEcCtD
Oxymorphone—Hypersensitivity—Methotrexate—germ cell cancer	0.00117	0.00136	CcSEcCtD
Oxymorphone—CYP2D6—cerebellum—germ cell cancer	0.00116	0.00814	CbGeAlD
Oxymorphone—Asthenia—Methotrexate—germ cell cancer	0.00114	0.00133	CcSEcCtD
Oxymorphone—Pruritus—Methotrexate—germ cell cancer	0.00112	0.00131	CcSEcCtD
Oxymorphone—Diarrhoea—Methotrexate—germ cell cancer	0.00108	0.00126	CcSEcCtD
Oxymorphone—Dizziness—Methotrexate—germ cell cancer	0.00105	0.00122	CcSEcCtD
Oxymorphone—Vomiting—Methotrexate—germ cell cancer	0.00101	0.00118	CcSEcCtD
Oxymorphone—Dermatitis—Methotrexate—germ cell cancer	0.000998	0.00116	CcSEcCtD
Oxymorphone—Headache—Methotrexate—germ cell cancer	0.000993	0.00116	CcSEcCtD
Oxymorphone—CYP2D6—brain—germ cell cancer	0.000944	0.00661	CbGeAlD
Oxymorphone—Nausea—Methotrexate—germ cell cancer	0.000941	0.0011	CcSEcCtD
